Daniel Markowitz CFA
Stock Analyst at Evercore ISI
(4.33)
# 1,337
Out of 4,966 analysts
64
Total ratings
60%
Success rate
22%
Average return
Main Sectors:
Stocks Rated by Daniel Markowitz CFA
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MMED MiniMed Group | Reiterated: Buy | $20 → $27 | $22.50 | +20.00% | 4 | Sep 2, 2026 | |
| NTRA Natera | Reiterated: Buy | $300 → $360 | $328.93 | +9.45% | 9 | Aug 7, 2026 | |
| PODD Insulet | Reiterated: Buy | $180 | $131.96 | +36.40% | 6 | Aug 6, 2026 | |
| INSP Inspire Medical Systems | Reiterated: Hold | $40 → $54 | $73.00 | -26.03% | 9 | Aug 4, 2026 | |
| WST West Pharmaceutical Services | Reiterated: Buy | $410 → $425 | $345.24 | +23.10% | 10 | Jul 27, 2026 | |
| RGEN Repligen | Reiterated: Buy | $140 → $160 | $165.18 | -3.14% | 9 | Jul 6, 2026 | |
| TMDX TransMedics Group | Reiterated: Buy | $118 → $90 | $82.18 | +9.52% | 6 | Jul 6, 2026 | |
| TECH Bio-Techne | Rated: Hold | $54 → $50 | $72.12 | -30.67% | 6 | May 7, 2026 | |
| DXCM DexCom | Initiated Coverage: Hold | $68 | $83.03 | -18.10% | 1 | Nov 26, 2025 | |
| GH Guardant Health | Reiterated: Buy | $68 → $90 | $157.38 | -42.81% | 4 | Oct 30, 2025 |
MiniMed Group
Sep 2, 2026
Reiterated: Buy
Price Target: $20 → $27
Current: $22.50
Upside: +20.00%
Natera
Aug 7, 2026
Reiterated: Buy
Price Target: $300 → $360
Current: $328.93
Upside: +9.45%
Insulet
Aug 6, 2026
Reiterated: Buy
Price Target: $180
Current: $131.96
Upside: +36.40%
Inspire Medical Systems
Aug 4, 2026
Reiterated: Hold
Price Target: $40 → $54
Current: $73.00
Upside: -26.03%
West Pharmaceutical Services
Jul 27, 2026
Reiterated: Buy
Price Target: $410 → $425
Current: $345.24
Upside: +23.10%
Repligen
Jul 6, 2026
Reiterated: Buy
Price Target: $140 → $160
Current: $165.18
Upside: -3.14%
TransMedics Group
Jul 6, 2026
Reiterated: Buy
Price Target: $118 → $90
Current: $82.18
Upside: +9.52%
Bio-Techne
May 7, 2026
Rated: Hold
Price Target: $54 → $50
Current: $72.12
Upside: -30.67%
DexCom
Nov 26, 2025
Initiated Coverage: Hold
Price Target: $68
Current: $83.03
Upside: -18.10%
Guardant Health
Oct 30, 2025
Reiterated: Buy
Price Target: $68 → $90
Current: $157.38
Upside: -42.81%